Your session is about to expire
← Back to Search
Study Summary
This trial aims to improve the health of Penn State patients with pre-diabetes and also decrease the costs associated with type 2 diabetes and its complications.
- Prediabetes
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this experiment in progress and open to new participants?
"Clinicaltrials.gov information reveals that registration for this clinical trial has ceased; the study was first published on May 25th 2021 and its last update occurred October 7th 2022. Although enrollment is not possible at present, there are 1291 other medical studies currently recruiting patients."
What are the eligibility criteria for joining this experiment?
"This clinical trial seeks 30 participants, aged between 18 and 64, who have been diagnosed with diabetes mellitus. Additional requirements must be fulfilled by potential enrollees: they should not be pregnant during the time of enrollment; they can't have a pre-existing diagnosis of either type 1 or 2 diabetes; need to maintain an active patient status at Penn State Health clinic in Pennsylvania (at least one visit within the last 18 months); own either an iPhone running iOS 10+ or Android 7+ smartphone which is carried during waking hours; possess internet access for data collection purposes; present with BMI ≥25 kg/m2 (or 23 kg/m"
Are adults of legal age able to participate in this research study?
"Eligibility for this specific trial requires potential participants to fall within the 18-64 age range. In contrast, there are separate medical trials tailored towards those younger than 18 (188 trials) and seniors above 65 years old (973)."
What ultimate goal is this clinical experiment hoping to accomplish?
"The primary objective of the trial, which will be monitored for a year's duration is to assess Weight loss. There are also three secondary goals which include tracking Blood Pressure through regular readings, measuring A1c levels throughout the research period and assessing Quality of Life (SF-36) using surveys."
Share this study with friends
Copy Link
Messenger